Publications

5808 Results

Randomized trial of novantrone (N), bisantrene (B), andadriamycin (A) in advanced breast cancer.

Authors
JD Cowan;CK Osborne;JJ Costanzi;BA Neilan;JN Bickers;JA Neidhart;M Heller
Journal / Conference
ASCO 5:59(#228)
Year
1986
Research Committee(s)
Breast
Study Number(s)
SWOG-8203/04

Spirogermanium in the treatment of stage D2 adenocarcinoma ofthe prostate: A Southwest Oncology Group study.

Authors
JH Saiers;M Slavik;J Costanzi;ED Crawford
Journal / Conference
ASCO 5:111(#433)
Year
1986
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8217

Concurrent chemotherapy with VP-16/vincristine/adriamycin/cyclophosphamide (EVAC) versus alternating chemotherapy withVP-16/cis-platinum and vincristine/adriamycin/cyclophosphamide(VPP/VAC) in limited small cell lung cancer (SCLC): A Southwest Oncology Group study (SWOG).

Authors
GE Goodman;J Basko
Journal / Conference
ASCO 5:169(#663)
Year
1986
Research Committee(s)
Lung
Study Number(s)
SWOG-8232

Evaluation of cis-platinum and DTIC combination chemotherapy indisseminated melanoma: A Southwest Oncology Group Phase II pilotstudy.

Authors
J Fletcher;B Dana;W Jewell;R Townsend;W Fletcher
Journal / Conference
ASCO 5:131(#510)
Year
1986
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8237

Treatment for advanced non-small cell lung cancer (NSCLC):platinum and VP-16 (PVp) +MGBG (PVpM) vs. platinum and vinblastine(PVe) +mitomycin-C (PVeMI) vs. 5-FU + vincristine +mitomycin-C/cyclophosphamide + doxorubicin + platinum(FOMi/CAP).

Authors
J Weick;R Natale;J Crowley;B Hom;R Livingston
Journal / Conference
ASCO 5:177(#692)
Year
1986
Research Committee(s)
Lung
Study Number(s)
SWOG-8241

Unfavorable histology lymphoma with alternating CHOP-CVB. Aphase II Southwest Oncology Group study.

Authors
L Dabich;PN Grozea;JW Athens;RM O'Bryan;SE Jones;FS Morrison;S Dahlberg;C Coltman, Jr
Journal / Conference
Presented for poster presentation at ISH-Sydney Australia May 11-16
Year
1986
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8245

Evaluation of cis-platinum and DTIC combination chemotherapy indisseminated melanoma: A SWOG Phase II pilot study.

Authors
J Fletcher;B Dana;W Jewell;R Townsend;W Fletcher
Journal / Conference
ASCO 5:131(#510)
Year
1986
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8273

Sequential hemibody irradiation (HBI) or cyclophosphamide (CTX) + total body irradiation (RBI) + autologous bone marrow infusion (ABM) as consolidation for estrogen receptor, negative, disseminated breast cancer. A Southwest Oncology Group Study.

Authors
R. Livingston;B Griffin;S Schulman
Journal / Conference
AACR 27:205(#812)
Year
1986
Research Committee(s)
Breast
Study Number(s)
SWOG-8278

Combination cisplatin and dichloromethotrexate in advancedbladder cancer: A Southwest Oncology Group (SWOG) study.

Authors
RB Natale;HB Grossman;ED Crawford;JR Borst;W Tranum;BA Blumenstein
Journal / Conference
ASCO 5:104(#402)
Year
1986
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8308

Sequential chemotherapy and neutron irradiation (XRT) for limitednon small cell lung cancer (NSCLC): A Southwest Oncology Group study.

Authors
R Livingston;B Griffin;S Schulman
Journal / Conference
ASCO 5:169(#661)
Year
1986
Research Committee(s)
Lung
Study Number(s)
SWOG-8367